Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wollemi Capital is a global climate-focused investment firm that specializes in scaling emerging climate solutions across the food, agriculture, and biotechnology sectors. The firm bridges the growth capital gap by investing in companies that utilize synthetic biology and precision fermentation to produce sustainable ingredients and carbon-removal technologies. Notable investments include Loam Bio, which uses microbial technology for soil carbon sequestration, and Pluton Biosciences, a microbial discovery platform. Wollemi Capital operates with a dual focus on delivering top-tier financial returns and achieving quantifiable reductions in greenhouse gas emissions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wollemi.